Latest Word from FDA
The FDA reported to Congress last week, and very little useful information can be gleaned from this most recent round of guidance. The report emphasized that the agency continues to lack comprehensive data on various aspects of CBD safety. The agency performed some potency and safety testing in the years leading up to the passage of the 2018 Farm Bill, and another round in 2019. Products identified for 2019 testing included those marketed with disease claims and products intended for vulnerable populations. Products tested were marketed as tinctures/oils, capsules/powders, edibles, beverages, and pet treats or food.
The agency found that 33% of the products they tested contained within 20% of advertised potency, and further found that 4 of 10…
12.20.2024
45z guidance fails to appear; government scrambles to pass spending bill
The US government spending bill failed twice in as many days. If a deal is not reached by midnight on Friday December 20, some federal services will...
12.20.2024
US animal fats and oils end week softer across the board ahead of holiday slowdown
Prices for US animal fats and oils ended the week on a lower note on Friday December 20, with most markets trending downward ahead of the upcoming holiday week,...
12.20.2024
December cattle on feed down on month, year
Most US animal protein prices were rangebound for the week, though in wider ranges due to the impending Christmas and New Year's holiday closures.
The only significant price...